Over-the-counter drug

Home/Tag: Over-the-counter drug

The Stash, Volume 30: Innovative Industrial Properties = High Dividend Yield + Strong Earnings Growth

INNOVATIVE INDUSTRIAL PROPERTIES (IIPR) = HIGH DIVIDEND YIELD + STRONG EARNINGS GROWTH Innovative Industrial Properties (IIPR) – the leading cannabis-focused real estate investment trust (REIT) – is one of the best cannabis names for investors to evaluate. IIPR focuses on the acquisition, ownership, and management of specialized industrial properties leased to experienced, state-licensed operators for their [...]

2020-03-30T14:02:15+00:00February 12th, 2020|

The Stash, Volume 29: Canna Finance – Set to Emerge from the Trough of Disillusionment?

CANNA FINANCE: SET TO EMERGE FROM THE TROUGH OF DISILLUSIONMENT? In our Dec. 18, 2019 Stash report, we said that balance sheet strength will matter more than ever in 2020 as the cannabis industry funding environment tightens and deals dry up. We expand on this subject this week by analyzing how cannabis companies went from being [...]

2020-03-30T14:02:42+00:00February 5th, 2020|

The Stash, Volume 27: Hemp – Driving Sustainable Growth in the Cannabis Industry

HEMP: DRIVING SUSTAINABILE GROWTH IN THE CANNABIS INDUSTRY Hemp’s sustainable properties are expected to drive the 34% CAGR in the global industrial hemp market to $26.6 billion over the next five years. Hemp commonly refers to the industrial/commercial use of the cannabis stalk and seed for textiles, food, paper, body care products, detergents, plastics, and building [...]

2020-03-30T14:03:56+00:00January 22nd, 2020|
Go to Top